Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 |
filingDate |
2016-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018515421-A |
titleOfInvention |
Manufacture of multiple dose injection-prepared dendritic cell vaccine |
abstract |
This embodiment relates to an injectable multi-dose antigen pulsed dendritic cell (DC) vaccine approved by the FDA. In one embodiment, the activated antigen loaded DC vaccine comprises an initial immunization dose and multiple “booster” doses. Also provided is a method of blocking both HER-2 and HER-3 as a treatment in causing permanent tumor aging in HER-2-expressing breast cancer. Also provided is a combination of anti-estrogen therapy and anti-HER2 dendritic cell vaccine for ER positive / HER2 positive DCIS breast cancer patients. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020169178-A |
priorityDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |